Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldConference

3rd International Cancer Conference and Expo

3rd International Cancer Conference and Expo, Baltimore, USA during June 05-07, 2019. i- Cancer USA 2019

Add this event to your calendar: iCal   Google Calendar

Who should attend?

This includes researchers, clinicians, data analysts, commissioners, allied cancer professionals, policy makers, service managers, patients and third sector organisations. The Conference has gained an unrivalled reputation as a global platform for businesses and academicians in terms of addressing Bio-Engineering And Bio-Mechanics In Robotics, Neuro-Oncology, Molecular Pathology, Radiation Oncology, Cancer Proteomics, Cancer Stem Cells, New cancer therapies, Diagnostic issues, haematological rare cancers, International Rare Cancers Initiative, management issues, rare childhood cancers, Diagnostic tools and challenges, Regenerative Medicine, Breast Cancer and its Treatment related issues in the context of meeting the needs of the industry.

Details

With enthusiastic support of our Organizing Committee, we invite you to participate in the International Cancer Conference and Expo as a continuum of our previous successful conference, during March 21-23, 2018 in Baltimore, USA.

3rd International Cancer Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. i- Cancer USA 2019 aims in "Driving Innovative Cancer Science Towards Precision Medicine".

This conference provides a forum for exchange of ideas and authoritative views by eminent personalities in this exciting field, by bringing together Cancer Science, Drug Development, Nanotechnology in Cancer Treatment, Robotic Surgery, Therapies, Oncology, Clinical trials, Cancer imaging, Medical radiation, Cancer detection, Control and Prevention research professionals; Academicians, Doctors, Study sponsors, Related Associations & Societies; Executives from Bio-Engineering, Diagnosis Tools, Medical devices and Pharmaceutical industries around the globe. i- Cancer2019 will have a multidisciplinary focus and aim to give participants a unique opportunity to exchange knowledge and ideas with members of the community working to beat cancer.

This includes researchers, clinicians, data analysts, commissioners, allied cancer professionals, policy makers, service managers, patients and third sector organisations. The Conference has gained an unrivalled reputation as a global platform for businesses and academicians in terms of addressing Bio-Engineering And Bio-Mechanics In Robotics, Neuro-Oncology, Molecular Pathology, Radiation Oncology, Cancer Proteomics, Cancer Stem Cells, New cancer therapies, Diagnostic issues, haematological rare cancers, International Rare Cancers Initiative, management issues, rare childhood cancers, Diagnostic tools and challenges, Regenerative Medicine, Breast Cancer and its Treatment related issues in the context of meeting the needs of the industry.

i- Cancer USA 2019 offers unparalleled business, research opportunities and access to new markets in Cancer and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest.

Join us and witness the booming industry by participating at i- Cancer USA 2019 and give your career and business access to new opportunities from throughout the world.

Prices

Academic Registration/ Business Registration / Student Registration Early Bird (Till November 16, 2018)

Contact

john stewart
john@icancerconference.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.